Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
GlucoTrack, Inc. - SIC # 3840 -
Ticker
Exchange
SIC #
Website
Latest Ticker
GCTK
Nasdaq
3840
glucotrack.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for GlucoTrack, Inc.
Glucotrack Announces 3 New Patents to Monitor Blood Glucose
- Jan 29th, 2026 3:42 pm
Glucotrack Announces USPTO Approval for Issuance of Patents for Proprietary CBGM Platform
- Jan 29th, 2026 6:01 am
Glucotrack, Inc. Announces Pricing of $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules with a Single Institutional Investor
- Dec 30th, 2025 6:00 am
Glucotrack Reports Third Quarter 2025 Financial Results and Provides Update on Recent Corporate Highlights
- Nov 13th, 2025 2:05 pm
Glucotrack, Inc. Encourages Shareholders to Vote
- Nov 3rd, 2025 2:05 pm
Glucotrack Appoints Neuromodulation and Painful Diabetic Neuropathy Expert, Usman Latif, MD, MBA, to Clinical Advisory Team
- Oct 29th, 2025 2:05 pm
Glucotrack, Inc. Reminds Shareholders to Vote
- Oct 28th, 2025 6:00 am
Q3 Virtual Investor Summit: On-Demand Presentations Now Available
- Sep 30th, 2025 11:00 am
Presenting at the Investor Summit Q3 2025 on September 16; Watch the Live Stream for Free
- Sep 16th, 2025 6:00 am
BC-Most Active Stocks
- Sep 12th, 2025 8:30 am
Wall Street Set to Open Little Changed Friday Ahead of Consumer Sentiment Report
- Sep 12th, 2025 7:21 am
Exchange-Traded Funds Higher, Equity Futures Mixed Ahead of September Consumer Sentiment Report
- Sep 12th, 2025 7:12 am
Consumer Sentiment, Oil Inventory Reports Set for Release as US Futures Little Changed in Friday's Premarket Session
- Sep 12th, 2025 6:03 am
Glucotrack to Participate in the Q3 Virtual Investor Summit
- Sep 11th, 2025 6:00 am
Glucotrack Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights
- Aug 14th, 2025 2:05 pm
Glucotrack Expands Clinical Advisory Team Appointing David S. Hirsh, MD as Medical Director, Cardiology
- Aug 6th, 2025 6:30 am
Glucotrack to Exhibit at 2025 Association of Diabetes Care and Education Specialists Annual Meeting
- Jul 31st, 2025 6:30 am
Glucotrack Announces Repurchase of Series A Warrants
- Jul 8th, 2025 6:30 am
Sector Update: Health Care Stocks Advance Late Afternoon
- Jun 25th, 2025 2:04 pm
Top Midday Gainers
- Jun 25th, 2025 12:23 pm
Scroll